Skip to main content
. 2018 Nov 12;29(12):2890–2899. doi: 10.1681/ASN.2018040443

Figure 3.

Figure 3.

There was no evidence that the urinary albumin-to-creatinine ratio or eGFR was different between groups at any time point. Change in urine albumin-to-creatinine ratio and eGFR from baseline to study end. Data are expressed as estimated mean with 95% confidence interval. Comparative analyses are on the basis of a mixed model for repeated measurements, comparing the values over time between groups and accounting for within-participant correlation. P value for interaction between groups over time is shown. ACEi, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker.